<DOC>
	<DOC>NCT02067286</DOC>
	<brief_summary>The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B &amp; RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.</brief_summary>
	<brief_title>Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<criteria>Patients exhibiting 2 or more symptom groups characteristic of influenza and/or RSV at the time of visit or within the past 48 hours: 1. fever of at least 37.8 C (100F) 2. runny or stuffy nose 3. coughing, wheezing or difficulty breathing 4. sore throat, headache, extreme tiredness, or muscle aches 5. infants: decreased activity, irritability, poor feeding Subject who are able to understand and consent to participation; for minors under the age of 18, this includes a parent or legal guardian Patients who are undergoing antiviral medication now or within the last 7 days. Patients who received Nasal Spray Flu Vaccine within the last 6 weeks</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>